Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity

BMC Physiology

Table 1 Resveratrol effects on the levels of the different gut hormones tested during the four weeks of treatment.

Gut hormones	Control	RSV1	RSV2	RSV3	RSV4	Friedman test
GIP	104 ± 14	123 ± 25	168 ± 28	187 ± 33	175 ± 39	F = 11.6, df = 4, p = 0.021
GLP-1	673 ± 25	705 ± 34	899 ± 139	1088 ± 293	1080 ± 295	F = 0.7, df = 4, p = 0.949
PP	205 ± 17	206 ± 22	193 ± 18	148 ± 36	140 ± 33	F = 4.2, df = 4, p = 0.385
PYY	298 ± 11	299 ± 16	329 ± 23	293 ± 47	261 ± 57	F = 1.8, df = 4, p = 0.779

The gut hormone levels investigated were glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), pancreatic polypeptide (PP) and peptide YY (PYY). RSV1, 2, 3 and 4 represent the four successive weeks of RSV treatment. Values are expressed in pg/ml and they are given as mean ± SEM (n = 6)

ISSN: 1472-6793